http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#head http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#assertion http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#provenance http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#publicationInfo http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#assertion http://bio2rdf.org/drugbank:DB00233 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00233_DB00605 http://bio2rdf.org/drugbank:DB00605 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00233_DB00605 http://bio2rdf.org/drugbank_resource:DB00233_DB00605 http://purl.org/dc/terms/identifier drugbank_resource:DB00233_DB00605 http://bio2rdf.org/drugbank_resource:DB00233_DB00605 http://purl.org/dc/terms/title DDI between Aminosalicylic Acid and Sulindac - Risk of additive toxicity (e.g. bleed risk). Aminosalicylic acid may decrease the serum concentration of sulindac. Consider alternate therapy or monitor for changes in the therapeutic effects of sulindac and adverse effects of both agents if the interacting agent is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00233_DB00605 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00233_DB00605 http://www.w3.org/2000/01/rdf-schema#label DDI between Aminosalicylic Acid and Sulindac - Risk of additive toxicity (e.g. bleed risk). Aminosalicylic acid may decrease the serum concentration of sulindac. Consider alternate therapy or monitor for changes in the therapeutic effects of sulindac and adverse effects of both agents if the interacting agent is initiated, discontinued or dose changed. [drugbank_resource:DB00233_DB00605] http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#provenance http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#publicationInfo http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#signature.MCwCFG0qDnb3dUIR http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#signature.MCwCFG0qDnb3dUIR http://purl.org/nanopub/x/hasSignature MCwCFG0qDnb3dUIRU8HftzFKT/PfHoVzAhQBqSVx/ich2ZGJWMl6gn8LAW/NyQ== http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#signature.MCwCFG0qDnb3dUIR http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30 http://purl.org/dc/terms/created 2018-03-30T11:12:56.736+02:00 http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30#signature.MCwCFG0qDnb3dUIR http://bio2rdf.org/drugbank_resource:DB00233_DB00605_nanopub.RANb8iC_Grji7HNYVealkOqc0HJmmvMde8g492UDMmn30 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234